129 related articles for article (PubMed ID: 14767532)
1. Ectopeptidases are differentially expressed in hepatocellular carcinomas.
Röcken C; Carl-McGrath S; Gräntzdörffer I; Mantke R; Roessner A; Lendeckel U
Int J Oncol; 2004 Mar; 24(3):487-95. PubMed ID: 14767532
[TBL] [Abstract][Full Text] [Related]
2. The ectopeptidases CD10, CD13, CD26, and CD143 are upregulated in gastric cancer.
Carl-McGrath S; Lendeckel U; Ebert M; Wolter AB; Roessner A; Röcken C
Int J Oncol; 2004 Nov; 25(5):1223-32. PubMed ID: 15492809
[TBL] [Abstract][Full Text] [Related]
3. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
Röcken C; Licht J; Roessner A; Carl-McGrath S
J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153
[TBL] [Abstract][Full Text] [Related]
4. cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma.
Xiao SY; Wang HL; Hart J; Fleming D; Beard MR
Am J Pathol; 2001 Oct; 159(4):1415-21. PubMed ID: 11583969
[TBL] [Abstract][Full Text] [Related]
5. [CD143 expression in testicular germ cell tumors].
Franke FE; Pauls K; Kerkman L; Steger K; Fink L; Burkhardt E; Klonisch T; Bergmann M; Danilov SM
Verh Dtsch Ges Pathol; 2000; 84():199-209. PubMed ID: 11217441
[TBL] [Abstract][Full Text] [Related]
6. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.
Kehlen A; Lendeckel U; Dralle H; Langner J; Hoang-Vu C
Cancer Res; 2003 Dec; 63(23):8500-6. PubMed ID: 14679016
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin I-converting enzyme (CD143) is down-regulated in focal nodular hyperplasia of the liver.
Gräntzdörffer I; Lendeckel U; Carl-McGrath S; Roessner A; Röcken C
Am J Surg Pathol; 2004 Jan; 28(1):84-8. PubMed ID: 14707868
[TBL] [Abstract][Full Text] [Related]
8. ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis.
Huang J; Lin Y; Li L; Qing D; Teng XM; Zhang YL; Hu X; Hu Y; Yang P; Han ZG
Mol Carcinog; 2009 Feb; 48(2):130-40. PubMed ID: 18612997
[TBL] [Abstract][Full Text] [Related]
9. Fetal- and tumor-specific regulation of growth hormone receptor messenger RNA expression in human liver.
Zogopoulos G; Albrecht S; Pietsch T; Alpert L; von Schweinitz D; Lefèbvre Y; Goodyer CG
Cancer Res; 1996 Jul; 56(13):2949-53. PubMed ID: 8674047
[TBL] [Abstract][Full Text] [Related]
10. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
[TBL] [Abstract][Full Text] [Related]
12. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of neprilysin (neutral endopeptidase 24.11) in rat and human hepatocellular carcinomas.
Dragović T; Deddish PA; Tan F; Weber G; Erdös EG
Lab Invest; 1994 Jan; 70(1):107-13. PubMed ID: 8302012
[TBL] [Abstract][Full Text] [Related]
14. GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation.
Gramantieri L; Chieco P; Giovannini C; Lacchini M; Treré D; Grazi GL; Venturi A; Bolondi L
Hum Pathol; 2005 Nov; 36(11):1154-62. PubMed ID: 16260267
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma.
Batmunkh E; Tátrai P; Szabó E; Lódi C; Holczbauer A; Páska C; Kupcsulik P; Kiss A; Schaff Z; Kovalszky I
Hum Pathol; 2007 Oct; 38(10):1508-15. PubMed ID: 17640714
[TBL] [Abstract][Full Text] [Related]
16. Human cytomegalovirus infection downregulates expression of the cellular aminopeptidases CD10 and CD13.
Phillips AJ; Tomasec P; Wang EC; Wilkinson GW; Borysiewicz LK
Virology; 1998 Oct; 250(2):350-8. PubMed ID: 9792845
[TBL] [Abstract][Full Text] [Related]
17. In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers.
Hellerbrand C; Bataille F; Schlegel J; Hartmann A; Mühlbauer M; Schölmerich J; Büttner R; Hofstädter F; Bosserhoff AK
Liver Int; 2005 Apr; 25(2):357-66. PubMed ID: 15780062
[TBL] [Abstract][Full Text] [Related]
18. Expression of MAGE-1 and -3 genes and gene products in human hepatocellular carcinoma.
Kariyama K; Higashi T; Kobayashi Y; Nouso K; Nakatsukasa H; Yamano T; Ishizaki M; Kaneyoshi T; Toshikuni N; Ohnishi T; Fujiwara K; Nakayama E; Terracciano L; Spagnoli GC; Tsuji T
Br J Cancer; 1999 Nov; 81(6):1080-7. PubMed ID: 10576668
[TBL] [Abstract][Full Text] [Related]
19. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
[TBL] [Abstract][Full Text] [Related]
20. Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters.
Kanda M; Nomoto S; Nishikawa Y; Sugimoto H; Kanazumi N; Takeda S; Nakao A
J Surg Oncol; 2008 Sep; 98(3):190-6. PubMed ID: 18537151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
